Diabetes Health Services and Quality of Care
This team is looking at how diabetes health services are delivered in Mississauga and Peel in order to determine how COVID-19 impacted these services and ways in which quality of care can be improved moving forward.
- To collaboratively develop a dictionary of clinical (prevalence, processes of care indicators, complications) and patient-reported (patient-reported experience measures, patient-reported outcomes measures) indicators of diabetes health services and quality of care, and to quantify the baseline levels of these measures in Mississauga/Peel and the rest of Ontario (if feasible)
- To determine the association between team-based characteristics of primary care models and clinical indicators of diabetes health services and quality of care during the COVID-19 pandemic in Mississauga/Peel and Ontario
- To determine the association between age at diagnosis and clinical indicators of diabetes health services and quality of care in Mississauga/Peel and Ontario.
Calvin Ke, MD, PhD
Dr. Calvin Ke is an Assistant Professor in the Department of Medicine, University of Toronto, a clinician-scientist at the Toronto General Hospital Research Institute, and a staff endocrinologist at the Toronto General Hospital, University Health Network in Toronto. He has conducted diabetes research internationally across Canada, China, India, and Guyana. His research interests include the management and outcomes of type 2 diabetes, with a focus on young-onset type 2 diabetes and on Chinese and South Asian populations.
Baiju Shah, MD, PhD
Dr. Baiju Shah is a health services researcher and clinician-scientist in endocrinology. He is a staff physician and Head of the Division of Endocrinology at Sunnybrook Health Sciences Centre, and a Scientist at the Sunnybrook Research Institute. He is a Professor in the Department of Medicine and the Institute of Health Policy, Management and Evaluation at the University of Toronto, and a Senior Core Scientist at ICES. His research seeks to understand and improve the quality of care and long-term outcomes of people with diabetes. He has national and international leadership in several areas of research, including diabetes care in immigrant, indigenous and other disadvantaged populations; long-term cardiometabolic consequences for women following gestational diabetes; and novel models of healthcare delivery to improve outcomes